Sridhar Duvvuri

Sridhar Duvvuri has a diverse work experience in the field of clinical pharmacology and pharmacometrics. Sridhar is currently employed at Cerevel Therapeutics, where they hold the position of Vice President of Clinical Pharmacology and Pharmacometrics since April 2021. Prior to this role, they served as the Senior Director in the same department from January 2020 to March 2021, and as the Director from May 2019 to January 2020.

Before joining Cerevel Therapeutics, Sridhar worked at Pfizer for a substantial period. Sridhar began their journey with Pfizer in April 2010 as a Manager in the Clinical Pharmacology department and gradually moved up the ladder. Sridhar held the role of Associate Director from December 2011 to July 2014 and became the Director of Clinical Pharmacology from July 2014 to May 2019.

Earlier in their career, Sridhar worked at Wyeth Research (Pfizer) as a Senior Research Scientist. Their responsibilities included biopharmaceutics and pharmacokinetics research. Sridhar served as a Senior Research Scientist-I from January 2006 to March 2008 and then continued as a Senior Research Scientist II from an unspecified start date until March 2010.

Overall, Sridhar Duvvuri has gained extensive expertise in the field of clinical pharmacology and pharmacometrics through their various roles in both Cerevel Therapeutics and Pfizer.

Sridhar Duvvuri obtained a Bachelor of Science degree in Pharmaceutical Science from Kakatiya University, where they studied from 1996 to 2000. Subsequently, they pursued a PhD in Pharmaceutical Sciences at the University of Missouri-Kansas City, completing their doctoral studies from 2001 to 2005.